Mastermed E 200 – Deus Medical

$94.00

Description

Description

Buy Mastermed E 200 Injectable Steroid Online – Deus Medical

ACTIVE HALF-LIFE 4.5-5 days
 CLASSIFICATION Anabolic Steroid
 DOSAGE Men 300-700 mg/week
 ACNE Yes
 WATER RETENTION No
 HBR No
 HEPATOTOXICITY Low
 AROMATIZATION No
 MANUFACTURER Deus Medical
 WAREHOUSE EU Warehouse 2
 SUBSTANCE Drostanolone Enanthate,

$94.00

WHAT IS IT:

MASTERMED E 200 (Drostanolone Enanthate) is an injectable anabolic steroid with powerful androgenic effect. MASTERMED E 200 (Drostanolone Enanthate) is a truly unique compound which is very popular among many bodybuilders and athletes because of its ability to dry out the muscle while on a cycle. Also, with proper dosage, it significantly improves athletic performance. MASTERMED E 200 (Drostanolone Enanthate) is a long-acting variant of Masteron, and is best utilized in longer cycle lengths (upwards of 10 – 12 weeks or longer).
MASTERMED E 200 (Drostanolone Enanthate) is very popular and most commonly used in cutting cycles and pre-contest cycles.

HOW TO USE:

MASTERMED E 200 (Drostanolone Enanthate) dosage requirements do not need to be that high. Beginner dosage normally begins at 400 mg/week, though many bodybuilders who utilize it only for its anti-estrogenic or pre-contest effects could easily utilize 200 mg/week on top of other steroids in their cycle. Intermediate and advanced doses as high as 600 mg/week or higher (800 mg/week or more) can be used. Female users can use this compound at dosages ranging from 50-100 mg per week.

MASTERMED E 200 (Drostanolone Enanthate) exhibits a half-life of 7 – 10 days due to the Enanthate ester and should be administered twice per week, with each injection spaced evenly apart, to maintain stable and steady blood plasma levels.

SPECIAL PRECAUTIONS FOR STORAGE:

Store below 30°C.
Protect from light. Do not freeze.

Brand

Brand

Deus Medical

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Mastermed E 200 – Deus Medical”

Your email address will not be published. Required fields are marked *